esorubicin has been researched along with Malignant Melanoma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casazza, AM; Di Marco, A; Pratesi, G; Savi, G | 1 |
| Chang, A; Hochster, H; Hunt, M; Parkinson, DR; Smith, TJ | 1 |
| Green, M; Hochster, H; Hunt, M; Parkinson, D; Smith, T | 1 |
| Crivellari, D; Di Pietro, N; Frustaci, S; Galligioni, E; Gasparini, G; Lo Re, G; Monfardini, S; Tirelli, U | 1 |
| Alberts, DS; Braich, TA; Garewal, HS; Jones, SE; Miller, TP; Robertone, A; Salmon, SE | 1 |
2 trial(s) available for esorubicin and Malignant Melanoma
| Article | Year |
|---|---|
Phase II trial of carboplatin in patients with metastatic malignant melanoma. A report from the Eastern Cooperative Oncology Group.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Carboplatin; Doxorubicin; Female; Humans; Male; Melanoma; Middle Aged | 1993 |
Esorubicin (deoxydoxorubicin) has low grade activity in malignant melanoma. Results of an Eastern Cooperative Oncology Group study (EST 2685).
Topics: Adult; Aged; Antibiotics, Antineoplastic; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Melanoma; Middle Aged | 1990 |
3 other study(ies) available for esorubicin and Malignant Melanoma
| Article | Year |
|---|---|
Antitumor activity in mice of 4'-deoxydoxorubicin in comparison with doxorubicin.
Topics: Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Doxorubicin; Female; Leukemia, Experimental; Male; Mammary Neoplasms, Experimental; Melanoma; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Sarcoma, Experimental | 1983 |
Phase II trial of esorubicin in patients with advanced melanoma.
Topics: Adult; Aged; Doxorubicin; Drug Evaluation; Humans; Lymphatic Metastasis; Melanoma; Middle Aged | 1987 |
Phase II trial of esorubicin (4' deoxydoxorubicin) in cancers of the breast, colon, kidney, lung and melanoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Bone Marrow; Breast Neoplasms; Colonic Neoplasms; Doxorubicin; Drug Evaluation; Female; Heart; Humans; Kidney Neoplasms; Lung Neoplasms; Melanoma; Middle Aged; Tumor Stem Cell Assay | 1986 |